Skip to main content

Advertisement

Table 6 Change scores between-group and within-group in biological outcomes

From: Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial

   Mean (SD) Mean difference CI 95% t (p)  
CRP 5th week Experimental 4.09 (6.51) −2.48 −10.54 to 5.57 −0.63 (0.53) Between group
Control 6.57 (11.52)
CK 5th week Experimental 105.36 (44.17) −0.20 −37.92 to 37.50 −0.01 (0.99)
Control 105.57 (46.05)
   Mean (SD) Mean difference CI 95% t (p) Within group
Experimental Basal CRP 4.27 (5.81) 0.182 −0.47 to 0.84 0.61 (0.55)
5th week CRP 4.09 (6.51)
Control Basal CRP 5.36 (5.13) −1.21 −7.28 to 4.85 −0.43 (0.67)
5th week CRP 6.57 (11.52)
Experimental Basal CK 102.36 (39.08) −3.00 −16.17 to 10.17 −0.50 (0.62)
5th week CK 105.36 (44.17)
Control Basal CK 112.50 (43.57) 6.92 −12.19 to 26.05 0.78 (0.44)
5th week CK 105.57 (46.05)
  1. Abbreviations: CRP C-reactive Protein, CK Creatine Kinase, SD standard deviation, CI confidence interval